| 1 |
Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 2023;41:450-65. [PMID: 36917950 DOI: 10.1016/j.ccell.2023.02.014] [Reference Citation Analysis]
|
| 2 |
Zhang J, Hu C, Xie X, Qi L, Li C, Li S. Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy. Vaccines 2023;11:614. [DOI: 10.3390/vaccines11030614] [Reference Citation Analysis]
|
| 3 |
Yamamoto J, Ohuchi K, Amagai R, Roh Y, Endo J, Chiba H, Tamabuchi E, Kambayashi Y, Hashimoto A, Asano Y, Fujimura T. CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas. Skin Health and Disease 2023. [DOI: 10.1002/ski2.222] [Reference Citation Analysis]
|
| 4 |
Zhou R, Bu W, Fan Y, Du Z, Zhang J, Zhang S, Sun J, Li Z, Li J. Dynamic Changes in Serum Cytokine Profile in Rats with Severe Acute Pancreatitis. Medicina (Kaunas) 2023;59. [PMID: 36837523 DOI: 10.3390/medicina59020321] [Reference Citation Analysis]
|
| 5 |
Feigl FF, Stahringer A, Peindl M, Dandekar G, Koehl U, Fricke S, Schmiedel D. Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B. Int J Mol Sci 2023;24. [PMID: 36834542 DOI: 10.3390/ijms24043129] [Reference Citation Analysis]
|
| 6 |
Li J, Yang C, Zheng Y. Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses. Front Genet 2022;13:1088230. [PMID: 36685946 DOI: 10.3389/fgene.2022.1088230] [Reference Citation Analysis]
|
| 7 |
Cook P, Kim J, Pena J, Mcqueen H, Kong L, Michael D. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.. [DOI: 10.21203/rs.3.rs-2264736/v1] [Reference Citation Analysis]
|
| 8 |
Shesternya PA, Savchenko AA, Gritsenko OD, Vasileva AO, Kudryavtsev IV, Masterova AA, Isakov DV, Borisov AG. Features of Peripheral Blood Th-Cell Subset Composition and Serum Cytokine Level in Patients with Activity-Driven Ankylosing Spondylitis. Pharmaceuticals (Basel) 2022;15. [PMID: 36355542 DOI: 10.3390/ph15111370] [Reference Citation Analysis]
|
| 9 |
Li J, Li X, Huang H, Tao L, Zhang C, Xie Y, Jiang Y. Role of SERCA3 in the Prognosis and Immune Function in Pan-Cancer. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9359879] [Reference Citation Analysis]
|
| 10 |
Yu Q, Zhang F, Feng D, Li D, Xia Y, Gan M. An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma. Front Genet 2022;13:866696. [DOI: 10.3389/fgene.2022.866696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Freff J, Beins EC, Bröker L, Schwarte K, Leite Dantas R, Maj C, Arolt V, Dannlowski U, Nöthen MM, Baune BT, Forstner AJ, Alferink J. Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder. J Affect Disord 2022;310:343-53. [PMID: 35526724 DOI: 10.1016/j.jad.2022.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Yero A, Shi T, Routy J, Tremblay C, Durand M, Costiniuk CT, Jenabian M. FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation. Front Immunol 2022;13:962912. [DOI: 10.3389/fimmu.2022.962912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
Fallati A, Di Marzo N, D'Amico G, Dander E. Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche. Cancers (Basel) 2022;14:3303. [PMID: 35884364 DOI: 10.3390/cancers14143303] [Reference Citation Analysis]
|
| 14 |
Xing XL, Liu Y, Liu J, Zhou H, Zhang H, Zuo Q, Bu P, Duan T, Zhou Y, Xiao Z. Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma. Front Immunol 2022;13:851312. [PMID: 35619698 DOI: 10.3389/fimmu.2022.851312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Takei J, Suzuki H, Asano T, Tanaka T, Kaneko MK, Kato Y. Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-Terminal Peptide Immunization. Monoclon Antib Immunodiagn Immunother 2022;41:87-93. [PMID: 35471046 DOI: 10.1089/mab.2021.0064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Kim JG, Peña JV, Mcqueen HP, Kong L, Michael D, Cook PR. Interferon regulatory factor 3 upregulates the Treg recruitment factor CCL22 in response to double-stranded DNA in cancer cells.. [DOI: 10.1101/2022.03.08.483519] [Reference Citation Analysis]
|
| 17 |
Erlichman N, Baram T, Meshel T, Morein D, Da'adoosh B, Ben-Baruch A. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers (Basel) 2022;14:1042. [PMID: 35205789 DOI: 10.3390/cancers14041042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Schlecht-Louf G, Deback C, Bachelerie F. The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy. Cancers (Basel) 2022;14:848. [PMID: 35159113 DOI: 10.3390/cancers14030848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Matsuo K, Yoshie O, Nakayama T. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers (Basel) 2021;13:6132. [PMID: 34885241 DOI: 10.3390/cancers13236132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
